151 related articles for article (PubMed ID: 25845464)
1. Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
Turan I; Yapali S; Bademkiran F; Kose T; Duman S; Sozbilen M; Gunsar F; Ersoz G; Akarca US; Ozutemiz O; Karasu Z
Liver Transpl; 2015 Aug; 21(8):1066-75. PubMed ID: 25845464
[TBL] [Abstract][Full Text] [Related]
2. A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.
Lin KH; Chen YL; Lin PY; Hsieh CE; Ko CJ; Lin CC; Ming YZ
Exp Clin Transplant; 2017 Feb; 15(1):65-68. PubMed ID: 28004999
[TBL] [Abstract][Full Text] [Related]
3. Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease.
Cholongitas E; Vasiliadis T; Goulis I; Fouzas I; Antoniadis N; Papanikolaou V; Akriviadis E
J Viral Hepat; 2015 Jul; 22(7):574-80. PubMed ID: 25385239
[TBL] [Abstract][Full Text] [Related]
4. Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease.
Lee WC; Wu TH; Wang YC; Cheng CH; Lee CF; Wu TJ; Chou HS; Chan KM; Lee CS
Biomed Res Int; 2017; 2017():9324310. PubMed ID: 28884132
[TBL] [Abstract][Full Text] [Related]
5. Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early termination.
Yang YW; Tsai MK; Yang CY; Lee CY; Chiang BL; Lai HS
Clin Exp Nephrol; 2020 May; 24(5):474-482. PubMed ID: 32219622
[TBL] [Abstract][Full Text] [Related]
6. Telbivudine improves renal function in patients with chronic hepatitis B.
Gane EJ; Deray G; Liaw YF; Lim SG; Lai CL; Rasenack J; Wang Y; Papatheodoridis G; Di Bisceglie A; Buti M; Samuel D; Uddin A; Bosset S; Trylesinski A
Gastroenterology; 2014 Jan; 146(1):138-146.e5. PubMed ID: 24067879
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection.
Wang L; Chen H; Fan C; Gong Z
J Med Virol; 2013 Nov; 85(11):1907-12. PubMed ID: 23852947
[TBL] [Abstract][Full Text] [Related]
8. Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
Mangus RS; Lutz AJ; Fridell JA; Kubal CA; Bush WJ; Tector AJ
Transplantation; 2015 Sep; 99(9):1855-61. PubMed ID: 26308416
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine.
Safadi R; Xie Q; Chen Y; Yin YK; Wei L; Hwang SG; Zuckerman E; Jia JD; Lopez P
Liver Int; 2011 May; 31(5):667-75. PubMed ID: 21040410
[TBL] [Abstract][Full Text] [Related]
10. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.
Tsai MC; Chen CH; Hung CH; Lee CM; Chiu KW; Wang JH; Lu SN; Tseng PL; Chang KC; Yen YH; Hu TH
Clin Microbiol Infect; 2014 Feb; 20(2):O90-O100. PubMed ID: 23659493
[TBL] [Abstract][Full Text] [Related]
11. Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis.
Han Z; Shi Y; Zhu J; Chen Y; Yin F; Xia L; Luo G; Gao Z; Liu J; Jia G; Li C; Zhou X; Han Y
J Viral Hepat; 2013 Apr; 20 Suppl 1():58-64. PubMed ID: 23458526
[TBL] [Abstract][Full Text] [Related]
12. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
Chang MS; Olsen SK; Pichardo EM; Stiles JB; Rosenthal-Cogan L; Brubaker WD; Guarrera JV; Emond JC; Brown RS
Transplantation; 2013 Apr; 95(7):960-5. PubMed ID: 23545507
[TBL] [Abstract][Full Text] [Related]
13. Pretransplant Type 2 Hepatorenal Syndrome Is Associated With Persistently Impaired Renal Function After Liver Transplantation.
Tan HK; Marquez M; Wong F; Renner EL
Transplantation; 2015 Jul; 99(7):1441-6. PubMed ID: 25643142
[TBL] [Abstract][Full Text] [Related]
14. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.
Lee M; Oh S; Lee HJ; Yeum TS; Lee JH; Yu SJ; Kim HY; Yoon JH; Lee HS; Kim YJ
J Viral Hepat; 2014 Dec; 21(12):873-81. PubMed ID: 24351112
[TBL] [Abstract][Full Text] [Related]
15. Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.
Lin CL; Chien RN; Yeh C; Hsu CW; Chang ML; Chen YC; Yeh CT
Scand J Gastroenterol; 2014 Dec; 49(12):1456-64. PubMed ID: 25283499
[TBL] [Abstract][Full Text] [Related]
16. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.
Fontana RJ; Hann HW; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Riker-Hopkins M; Brown N;
Liver Transpl; 2001 Jun; 7(6):504-10. PubMed ID: 11443577
[TBL] [Abstract][Full Text] [Related]
17. Renal outcomes after liver transplantation in the model for end-stage liver disease era.
Sharma P; Welch K; Eikstadt R; Marrero JA; Fontana RJ; Lok AS
Liver Transpl; 2009 Sep; 15(9):1142-8. PubMed ID: 19718633
[TBL] [Abstract][Full Text] [Related]
18. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH
Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis.
Chan HL; Chen YC; Gane EJ; Sarin SK; Suh DJ; Piratvisuth T; Prabhakar B; Hwang SG; Choudhuri G; Safadi R; Tanwandee T; Chutaputti A; Yurdaydin C; Bao W; Avila C; Trylesinski A
J Viral Hepat; 2012 Oct; 19(10):732-43. PubMed ID: 22967105
[TBL] [Abstract][Full Text] [Related]
20. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
